Detalhe da pesquisa
1.
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial.
Circulation
; 147(4): 284-295, 2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335517
2.
SGLT2 inhibitors: practical considerations and recommendations for cardiologists.
Curr Opin Cardiol
; 33(6): 676-682, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30148719
3.
The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial.
Nephrol Dial Transplant
; 35(5): 895-897, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32159783